Recently approved delays and exemptions to the CMS drug price negotiation program are projected to cost $8.8 billion over 10 years, according to a Congressional Budget Office report published Oct. 20.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback